The MRC Unit, The Gambia is undertaking a
randomised clinical trial that will examine the effects of administering
a pneumococcal-conjugate vaccine either to expectant mothers at between
28 and 34 weeks gestation, or to newborn infants, shortly following
birth, on pneumococcal carriage (as a surrogate of pneumococcal disease)
in early life.
The two groups will be compared to the routine 2, 3 and 4
month infant schedule currently recommended by WHO and used in The
Gambia. As well as assessing pneumococcal carriage and the
immunogenicity of the vaccines (including transplacental and breast milk
antibody transfer), safety follow-up of both mothers during pregnancy
and also their newborn infants will be central component of the trial.
Job Title: Research Clinician
Nursing Officer at Cedarcrest Hospitals Limited
Medical Doctor at Caring Habitat Global Limited
Nurse at Premiere Urgence Internationale
Sonographer at Redus Center for Digestive Health
Vacancies at Kashim Ibrahim University Teaching Hospital
Registered Nurse at IGPES Group
Medical Officer at IGPES Group
Specialist (M/F/D) for General Medicine at Julius Berger Nigeria Plc
Ongoing recruitment at The University of Maiduguri Teaching Hospital (UMTH)
Environment and Climate Change Officer at Africa Youth Growth Foundation
Relationship Manager at Citygate Global Investment Limited
HR / Admin Assistant at Platform Finance Company Limited
Chief Revenue Officer (CRO) - Remote at KloudOpp Limited
Full Stack Developer at Trade Lenda
Chief Legal Officer (CLO) at KloudOpp Limited - Remote
Chief People Officer (CPO) - Remote at KloudOpp Limited
Senior Sales Officer (Remote) at KloudOpp Limited